Agrastat

Agrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain medical procedures to reduce the risk of clot formation. This medication is manufactured by Advanz Pharma Limited.

Agrastat is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI), a procedure to open blocked coronary arteries. It works by inhibiting platelet aggregation, which is essential for clot formation. Patients may be prescribed Agrastat to manage conditions where there is a high risk of blood clots, such as during heart procedures. What is Agrastat used for? It is used for preventing clot formation in specific medical scenarios.

Common effects of Agrastat may include bleeding, bruising, and prolonged bleeding from cuts or injuries. Some patients may experience nausea, headache, or dizziness. These effects are generally mild and temporary, but any severe or persistent symptoms should be discussed with a healthcare provider.

Agrastat should be handled with care, as it is intended for intravenous use only. It is important to follow the administration guidelines provided by a healthcare professional. Patients with a history of bleeding disorders or recent surgery should inform their healthcare provider before using Agrastat. Proper storage and handling are crucial to maintain the medication's effectiveness.

Agrastat may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the way Agrastat works, so it is advisable to consult with a healthcare professional before making any changes to your regimen.